Fundz

Who to call at Entos Pharmaceuticals, and when

Fundz watches for the moments Entos Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Entos Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Entos Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics

Mar 12, 2025

Contract Type

partnership

EdmontonBiotechnologyHealth CareGeneticsTherapeutics

Description

Entos Pharmaceuticals has announced a $198.5 million partnership with the Governments of Canada and Alberta to accelerate the biomanufacturing of Fusogenix PLV next generation therapeutics. The investment will help build an R&D center and a GMP manufacturing facility in Edmonton, Alberta, aiming to foster collaborations between Entos, Canadian academic institutions, and its industry partners.

Company Information

Company

Entos Pharmaceuticals

Location

Edmonton, England, United Kingdom

About

Entos Pharmaceuticals is a clinical-stage genetic medicines company focused on developing cures and improving patients' lives using its proprietary Fusogenix™ PLV™ technology. The company aims to address rare genetic disorders through innovative genetic medicine approaches. Since its founding in 2016, Entos has been committed to advancing next-generation genetic medicines.

Related People

Jason
Likely contact at this company
••••••••@••••••••

See Jason's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Entos Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Entos Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.